Composite
52%
Novelty
55%
Feasibility
55%
Impact
60%
Mechanistic
65%
Druggability
55%
Safety
50%
Confidence
53%

Mechanistic description

VPS35 Retromer Restoration to Rescue Endosomal Protein Trafficking

Evidence for (5)

  • VPS35 mutations cause autosomal-dominant Parkinson's disease with synaptic dysfunction

  • Retromer protein levels are reduced in AD hippocampus and correlate with cognitive decline

  • Retromer dysfunction causes APP mislocalization to endosomes, increasing Aβ production

  • R55 compound rescues VPS35 mutations and restores retromer function in cellular models

  • Retromer mediates retrieval of synaptic receptors (APP, Vps10, SorLA) from degradative pathway

Evidence against (6)

  • VPS35 mutations cause Parkinson's, not Alzheimer's - mechanistic disconnect

  • VPS35 overexpression in mouse models causes dopamine neuron degeneration

  • Retromer enhancement increases Aβ production in some cellular models by redirecting APP to amyloidogenic compartments

  • R55 compound validation limited to HeLa cells and yeast; no human neuron data

  • Retromer affects thousands of cargo including Wntless, glutamate receptors, transferrin receptor

  • Correlation between VPS35 levels and cognitive decline may be secondary to neurodegeneration

Bayesian persona consensus

53% posterior support

1 signal · 1 for / 0 against · agreement 100%

scidex.consensus.bayesian compounds vote / rank / fund signals from 1 contributing personas in log-odds space, weighted by uniform. Prior 50%.